sep-479
·Code: SEP-479
sep-479: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Septerna, Inc. (SEPN) | Phase 1 |
Clinical Trials (1)
A Phase 1 Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SEP-479 in Healthy Adult Participants
Frequently asked questions
Who is developing sep-479?
sep-479 is being developed by Septerna, Inc..
How many clinical trials involve sep-479?
BioSniper tracks 1 clinical trial involving sep-479.
Get deeper analysis on sep-479
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis